Fosinoprilum natricum
| Medicinal product name | Fosinopril Actavis 20 mg tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Tablet | ||||||
| Strength | 20 mg | ||||||
| Information from the MAH on shortages |
planned withdraw date: Apr 29, 2024 |
||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Reimbursed medicines reference product |
||||||
| Package leaflet |  21-06-2023
|
||||||
| Summary of product characteristics | 21-06-2023
|
||||||
| ATC code | C09AA09 – Agents acting on the renin-angiotensin system | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (13)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Is available (according to the information provided by wholesalers) (490 containers) planned withdraw date: Apr 29, 2024 |
Recipe Plus, Magnum Medical, Jelgavfarm, Baltfarm "Vita-Farm", Euroaptieka, Oribalt Rīga, Tamro |
N28 (20 mg) |
OPA/Al/PVC/Al blister |
€ 7.09 * |
05-0617-01 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-02 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-03 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-04 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-05 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N42 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-06 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-07 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-08 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (20 mg) |
OPA/Al/PVC/Al blister | 05-0617-09 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (20 mg) |
Polypropylene vial | 05-0617-10 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (20 mg) |
Polypropylene vial | 05-0617-11 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N250 (20 mg) |
Polypropylene vial | 05-0617-12 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N500 (20 mg) |
Polypropylene vial | 05-0617-13 |
Labelling text Jun 21, 2023 Labelling text Jun 21, 2023 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 05-0617 |
|---|---|
| Date of authorisation | Jan 18, 2006 |
| Marketing authorisation holder, country | Teva B.V., Netherlands |
